research
feel
term
immun
privileg
outdat
mislead
appli
central
nervou
system
cn
resid
brain
cell
microenviron
activ
modul
immun
respons
infect
insult
cn
present
uniqu
challeng
host
defens
like
tissu
immun
respons
within
cn
character
resid
macrophag
ie
microgli
cell
activ
persist
antibodi
produc
bcell
retent
virusspecif
memori
tcell
infectioninduc
inflamm
within
brain
dramat
increas
infiltr
migrat
tlymphocyt
play
critic
role
antivir
defens
howev
chronic
presenc
interferon
ifn
lymphocyt
may
damag
gener
nonregener
tissu
henc
addit
benefici
antivir
effect
turn
proinflammatori
neuroimmun
respons
suppress
inflamm
equal
import
limit
tissu
damag
preserv
neurolog
function
variou
immun
checkpoint
specif
tailor
restrain
exacerb
immun
respons
postvir
infect
varieti
inhibitori
molecul
contribut
tcell
regul
one
checkpoint
program
death
program
death
pathway
belong
famili
vital
control
interact
cell
involv
defens
brain
interact
play
critic
role
elicit
inhibitori
second
signal
requir
function
suppress
tcell
respons
commonli
refer
tcell
exhaust
exhaust
phenotyp
character
decreas
prolif
capac
cytokin
product
cytotox
effector
function
figur
correspondingli
function
blockad
interact
result
increas
effector
tcell
function
upregul
pathway
follow
infect
inflamm
drawn
much
attent
past
decad
interact
limit
immunemedi
tissu
damag
caus
overreact
tcell
especi
site
like
brain
also
evid
model
cn
autoimmun
signal
dampen
autoreact
tcell
respons
protect
cn
howev
need
better
understand
intric
balanc
antivir
neuroimmun
respons
necessari
effici
pathogen
clearanc
versu
accept
level
bystand
immunepatholog
damag
microgli
cell
astrocyt
oligodendrocyt
macrophag
dendrit
cell
neuron
varieti
nonhematopoiet
cell
type
includ
microvascular
endotheli
cell
well
epitheli
cell
express
cell
sever
nonlymphoid
tissu
muscl
heart
placenta
renal
tubular
cell
ocular
cell
cancer
line
also
express
cn
microgli
cell
origin
yolk
sac
progenitor
seed
brain
earli
develop
repres
approxim
total
glial
cell
mice
cnsresid
immun
cell
microglia
extrem
sensit
brain
injuri
diseas
function
bridg
cn
immun
system
autoimmun
neuroinflamm
microglia
serv
critic
cell
type
initi
also
regul
rapid
immun
respons
infect
first
line
host
defens
cn
modul
innat
cytokin
chemokin
product
adapt
tcell
activ
immun
function
requir
recruit
infiltr
effector
immun
cell
basal
level
express
approxim
microglia
uninfect
mice
induc
express
detect
cell
within
one
week
follow
viral
brain
infect
neuroinflamm
microgli
cell
well
astrocyt
upregul
along
mhc
mhc
ii
suggest
role
resid
glial
cell
limit
cn
patholog
given
microglia
present
antigen
tcell
express
express
inhibitori
costimulatori
molecul
like
microglia
affect
tcell
differenti
function
ie
product
proinflammatori
cytokin
besid
microgli
cell
astrocyt
also
play
import
role
suppress
cn
patholog
shown
human
astrocyt
upregul
express
treatment
proinflammatori
cytokin
decreas
activ
human
tcell
astrocyt
also
first
glial
cell
induc
major
histocompat
complex
mhc
ii
report
although
compar
microglia
express
astrocyt
slower
develop
less
robust
thu
deem
nonprofession
antigen
present
cell
importantli
clear
express
glia
temper
reactiv
microgliosi
well
astrocytosi
interestingli
b
tcell
may
express
augment
upon
activ
similarli
microglia
also
upregul
upon
infect
induc
inflamm
henc
exclud
possibl
microglia
tcell
interact
pathway
upregul
cn
occur
respons
presenc
inflammatori
cytokin
milieu
figur
upon
viral
infect
produc
braininfiltr
lymphocyt
result
enhanc
express
glial
cell
wherea
antigen
experienc
tcell
express
although
cultur
glial
cell
express
low
basal
level
express
upregul
upon
treatment
proinflammatori
cytokin
found
acut
chronic
brain
infect
undoubtedli
cytokin
secret
activ
tcell
respons
longterm
microgli
activ
product
case
neuroinflamm
local
within
area
strongest
inflamm
paradox
act
neg
regulatori
feedback
loop
keep
antiinflammatori
milieu
upregul
limit
cn
patholog
suppress
proinflammatori
cytokin
product
brain
infiltr
tcell
preponder
vs
tcell
cn
mice
indic
pathway
mainli
inhibit
function
cell
rather
cell
addit
block
interact
tcell
either
primari
murin
microglia
astrocyt
result
increas
product
similar
observ
increas
product
tcell
made
mice
indic
downregulatori
role
increas
express
induc
chemokin
receptor
follow
blockad
also
report
pathway
may
also
neg
regul
chemokin
express
moreov
synergist
action
infect
brain
increas
nitric
oxid
induc
neurodegener
induc
synthas
ino
effector
molecul
synthes
free
radic
implic
cytotox
close
associ
patholog
chang
variou
cn
disord
multipl
sclerosi
anim
correl
experiment
autoimmun
enceph
eae
trm
distinct
class
memori
tcell
selfrenew
highli
protect
subsequ
infect
perman
resid
site
infect
disconnect
circul
infiltr
tcell
persist
longterm
within
infect
brain
acquir
brainresid
trm
btrm
phenotyp
express
activ
glia
contribut
develop
notabl
high
express
btrm
inher
properti
ingrain
independ
antigen
inflamm
analys
postmortem
brainderiv
tcell
also
describ
express
btrm
howev
precis
mechan
signal
pathway
drive
express
btrm
remain
elucid
fact
tcell
organ
like
kidney
may
express
spite
similar
viral
persist
brain
indic
tissuerestrict
organdepend
induct
depend
upon
microenviron
moreov
perenni
express
btrm
regul
epigenet
level
brain
infect
gene
promot
first
undergo
extens
demethyl
becom
access
remain
perman
demethyl
interestingli
despit
express
btrm
effector
function
impair
infect
indic
exhaust
also
sustain
express
btrm
even
viral
clearanc
indic
role
control
effector
function
use
vivo
vitro
studi
demonstr
role
pathway
develop
btrm
use
murin
cytomegaloviru
mcmv
infect
model
shown
knockout
anim
display
reduc
number
tcell
express
btrm
phenotyp
within
chronicallyinfect
brain
compar
wild
type
anim
subsequ
vitro
studi
also
identifi
role
glia
promot
develop
retent
btrm
block
either
microglia
astrocyt
result
reduc
express
along
reduc
tcell
signatur
marker
btrm
anoth
studi
use
theiler
murin
encephalomyel
viru
tmev
also
demonstr
critic
role
mainten
btrm
postacut
enceph
viral
clearanc
author
demonstr
resolut
acut
enceph
effector
tcell
develop
trm
persist
within
brain
absenc
replic
viru
tcell
adopt
transfer
studi
demonstr
promot
mainten
btrm
cn
restrict
accumul
proinflammatori
tcell
also
play
import
role
control
secondari
viru
challeng
lack
result
function
defect
btrmmediat
viru
control
knockout
anim
report
also
indic
treat
btrm
result
increas
product
inflammatori
cytokin
henc
influenc
accumul
virusspecif
trm
also
affect
cytokin
product
brain
cn
uniqu
featur
make
reservoir
allow
persist
replicationcompet
viru
brain
cell
harbor
variou
persist
latent
viral
genom
cell
gener
longliv
halfliv
rang
month
year
may
infect
high
frequenc
know
overact
chronic
immun
activ
within
cn
detriment
sensit
neuron
result
focal
immunopatholog
correspond
neurolog
deficit
sever
studi
examin
pathway
cn
infect
review
primarili
discuss
find
variou
murin
model
previous
shown
ko
anim
display
significantli
greater
mechan
hypersensit
wild
type
mice
chronic
murin
retrovir
infect
associ
significantli
increas
infiltr
tlymphocyt
macrophag
microgli
activ
mcmvinduc
brain
infect
chronic
neuroinflamm
persist
within
postencephalit
brain
even
absenc
detect
viral
antigen
use
model
schachtel
et
al
demonstr
activ
brainresid
glial
cell
upregul
respons
produc
infiltr
tlymphocyt
control
antivir
respons
function
inhibit
effector
tcell
via
pathway
therebi
limit
deleteri
consequ
unrestrain
neuroinflamm
extens
studi
murin
model
illustr
immunoregulatori
role
microgli
cell
chronic
persist
neuroinflamm
express
microglia
well
astrocyt
oligodendrocyt
also
report
neg
regul
tcell
activ
limit
immun
mediat
tissu
damag
model
multipl
sclerosi
ms
well
acut
viral
enceph
human
postmortem
studi
express
observ
microglia
astrocyt
demyelin
diseas
ms
brain
lesion
normal
control
studi
hu
et
al
report
compar
control
microglia
eae
mice
upregul
along
mhc
ii
use
ex
vivo
cocultur
microglia
eae
mice
inhibit
antigenspecif
tcell
prolifer
well
differenti
via
whose
product
depend
suppress
eae
sever
diseas
progress
demonstr
use
knockout
anim
defici
lead
aggrav
symptom
eae
well
adopt
transfer
microglia
express
attenu
sever
establish
eae
demonstr
import
regulatori
role
neuroinflamm
antiinflammatori
respons
within
brain
undoubtedli
benefici
host
establish
prolong
antiinflammatori
milieu
may
also
lead
defici
viral
clearanc
use
gliatrop
jhm
strain
mous
hepat
coronaviru
result
acut
encephalomyel
mice
phare
et
al
shown
transient
express
microglia
astrocyt
higher
sustain
express
oligodendrocyt
suggest
celltyp
specif
role
cn
infect
moreov
upregul
express
microglia
oligodendroglia
activ
viral
infect
found
suppress
tcell
function
author
also
highlight
noncompensatori
role
tcell
help
optim
tcell
antivir
function
effector
site
blockad
author
report
heighten
neuroinflammatori
respons
via
product
increas
granzym
b
cn
infiltr
tcell
ultim
lead
rapid
clearanc
viru
cn
decreas
viral
persist
jhminfect
mice
howev
come
cost
mice
display
quicker
onset
clinic
symptom
ie
loss
axon
integr
higher
rate
morbid
mortal
anim
succumb
infect
associ
sustain
microgli
cell
macrophag
ino
well
express
absenc
increas
myelin
loss
suggest
protect
oligodendrocyt
directli
immun
attack
rather
dampen
ongo
immun
activ
author
report
modul
tcell
effector
function
lead
detriment
bystand
damag
noninfect
cell
despit
effect
viral
control
studi
highlight
role
mediat
protect
viralinduc
immunopatholog
associ
encephalomyel
similarli
duncan
et
al
demonstr
upregul
level
microglia
follow
stimul
activ
tmevinduc
demyelin
diseas
tmevidd
anim
model
multipl
sclerosi
util
neutral
antibodi
demonstr
suppress
tmevinduc
ex
vivo
product
cnsinfiltr
tcell
support
regulatori
function
tcell
control
howev
vivo
blockad
sjlj
mice
use
neutral
antibodi
minim
effect
viral
clearanc
significantli
exacerb
sever
clinic
diseas
symptom
ie
increas
mortal
chronic
autoimmun
phase
tmevidd
presum
exacerb
immunemedi
damag
use
myelin
oligodendrocyt
model
eae
report
adopt
transfer
wildtyp
encephalitogen
tcell
recipi
mice
result
enhanc
sever
eae
diseas
anim
moreov
defici
convert
strain
resist
eaesuscept
demonstr
critic
role
limit
pathogen
effector
tcell
respons
jun
et
al
report
role
pathogenesi
herpet
stromal
kerat
hsk
caus
herp
simplex
viru
type
infect
cornea
mice
administr
monoclon
antibodi
acceler
develop
sever
hsk
correl
increas
prolifer
specif
tcell
product
contrast
express
infect
neuron
driven
ensu
rabi
viru
infect
prevent
viral
control
result
neuroinvas
enhanc
cn
viral
load
mortal
henc
case
defici
rescu
mice
fatal
rabi
viru
infect
mani
neurotrop
infect
express
neuron
provid
select
surviv
advantag
viru
thu
blockad
therapi
envis
possibl
therapeut
approach
context
glioma
major
primari
cancer
cn
complex
network
involv
posit
neg
immun
regul
tumor
site
similar
pathogen
exploit
pathway
establish
persist
express
brain
tumor
serv
immun
evas
strategi
mani
human
carcinoma
tcell
tumor
express
cell
surfac
recent
express
shown
upregul
tumorassoci
macrophagesmicroglia
case
primari
central
nervou
system
lymphoma
report
tumor
cell
express
grow
wildtyp
mice
regress
mice
data
suggest
tumor
may
limit
tcell
clonal
expans
therebi
attenu
tumorspecif
respons
find
suggest
inhibitori
signal
grant
tumor
select
growth
advantag
inhibit
tcell
respons
immun
checkpoint
inhibitor
function
tumorregress
factor
via
modul
immun
celltumor
cell
interact
reactiv
cytotox
tcell
work
cancer
cell
recent
saha
et
al
demonstr
two
glioma
model
tripl
combin
therapi
anticytotox
tlymphocyt
associ
protein
ctla
oncolyt
hsv
express
murin
cure
mice
glioblastoma
cur
effect
associ
macrophag
influx
along
increas
teffector
tregulatori
cell
ratio
first
checkpoint
inhibitor
approv
treatment
unresect
melanoma
fda
ipilimumab
target
pathway
despit
earli
achiev
use
inhibit
wide
use
success
immun
checkpoint
inhibitor
current
monoclon
antibodi
target
pembrolizumab
nivolumab
ligand
atezolizumab
avelumab
durvalumab
inhibitori
antibodi
use
frontlin
treatment
variou
type
cancer
metastat
melanoma
nonsmal
cell
lung
cancer
nsclc
renal
cell
carcinoma
rcc
bladder
urotheli
cancer
moreov
effort
made
consid
numer
cancer
type
includ
breast
head
neck
advanc
solid
hematolog
malign
past
year
immunotherapeut
approach
use
checkpoint
inhibitor
provid
substanti
improv
treatment
otherwis
devast
malign
convent
therapi
limit
success
despit
huge
success
efficaci
antipd
therapeut
respons
limit
specif
type
cancer
attribut
insuffici
heterogen
express
tumor
milieu
moreov
respons
individu
patient
suscept
particular
cell
type
remain
highli
variabl
difficult
predict
addit
target
immun
checkpoint
blockad
augment
antitumor
immun
also
may
induc
specif
immunerel
advers
event
ira
offtarget
toxic
eg
neurolog
toxic
innoc
bystand
inflammatori
side
effect
like
account
much
ira
besid
affect
gastrointestin
tract
endocrin
gland
skin
liver
ira
often
involv
nervou
system
immun
checkpoint
blockad
therapi
result
inflamm
brain
caus
enceph
asept
mening
patient
receiv
pathway
blockad
therapi
along
radiat
melanoma
brain
metastas
report
seizur
cognit
chang
neurolog
dysfunct
perilesion
edema
toxic
precis
mechan
behind
ira
clear
appear
mainli
attribut
event
mediat
antibodi
tcell
cytokin
storm
recommend
patient
high
risk
ira
consid
treatment
immun
checkpoint
blockad
weigh
risk
benefit
drug
target
pathway
demonstr
efficaci
stimul
tcell
respons
could
potenti
aid
erad
persist
viru
clinic
trial
current
underway
determin
whether
intraven
administr
pembrolizumab
safe
toler
hivposit
peopl
import
potenti
exist
immun
checkpoint
inhibitor
treatmentrel
toxic
advers
event
especi
within
cn
strike
balanc
immun
inflamm
within
brain
critic
linger
cognit
impair
seen
patient
hivassoci
neurocognit
disord
hand
success
cart
believ
relat
persist
lowlevel
cn
infect
accompani
local
immun
activ
unfortun
less
known
safeti
antipd
therapi
patient
hiv
infect
studi
davar
et
al
report
therapi
could
safe
given
patient
melanoma
nsclc
also
hiv
infect
preferenti
safe
use
inhibitor
convent
drug
random
control
trial
includ
patient
advanc
metastat
cancer
report
henc
potenti
toxic
neuroinflammatori
event
associ
checkpoint
blockad
manag
case
taken
togeth
find
suggest
blockad
pathway
may
provid
mean
boost
antivir
immun
appear
safe
patient
chronic
viral
infect
howev
concern
shown
use
anim
model
blockad
antibodi
deliv
system
abl
enter
cn
acut
viral
infect
make
therapeut
target
pathway
within
cn
use
antibodybas
therapi
challeng
howev
recent
review
highlight
tcell
mediat
antibodi
access
therebi
block
replic
neurotrop
virus
novel
insight
provid
key
foundat
enabl
use
antibodi
therapi
variou
viral
brain
infect
well
brain
metastas
longterm
persist
neuroinflamm
commonli
seen
neurodegen
diseas
stroke
viral
brain
infect
care
manag
overreact
chronic
immun
activ
detriment
sensit
neuron
cell
result
neurotox
secondari
neuron
injuri
subsequ
neurocognit
dysfunct
well
behavior
deficit
moreov
reactiv
microgliosi
link
synapt
dysfunct
loss
affect
learn
memori
suggest
extend
neuroinflamm
may
harm
brain
review
focuss
understand
elev
sustain
level
neg
checkpoint
molecul
regul
virusspecif
tcell
respons
restrain
chronic
neuroinflamm
express
microglia
astrocyt
oligodendroglia
neuron
provid
accumul
evid
critic
immunemodul
cn
diseas
distinct
upregul
activ
glia
emphas
propens
cnsresid
cell
interact
lymphocyt
therefor
elimin
protect
function
acceler
control
viral
infect
may
compromis
enhanc
immunemedi
tissu
damag
still
modul
pathway
hold
promis
therapeut
potenti
checkpoint
blockad
may
provid
novel
therapeut
approach
enhanc
antivir
activ
clearanc
viral
brain
reservoir
